Search Results - "Abramowicz, D."

Cell‐Free DNA: An Upcoming Biomarker in Transplantation by Gielis, E. M., Ledeganck, K. J., De Winter, B. Y., Del Favero, J., Bosmans, J.‐L., Claas, F. H. J., Abramowicz, D., Eikmans, M.

“…After organ transplantation, donor‐derived cell‐free DNA (ddcfDNA) can be detected in the recipient's blood and urine. Different ddcfDNA quantification…”
Get full text

Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies? by Hellemans, R., Bosmans, J.‐L., Abramowicz, D.

“…Induction therapy with antilymphocyte biological agents is widely used after kidney transplantation, most commonly T lymphocyte‐depleting rabbit‐derived…”
Get full text

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients by Humar, A., Lebranchu, Y., Vincenti, F., Blumberg, E. A., Punch, J. D., Limaye, A. P., Abramowicz, D., Jardine, A. G., Voulgari, A. T., Ives, J., Hauser, I. A., Peeters, P.

“…Late‐onset cytomegalovirus (CMV) disease is a significant problem with a standard 3‐month prophylaxis regimen. This multicentre, double‐blind, randomized…”
Get full text

Operational tolerance in kidney transplantation and associated biomarkers by Massart, A., Ghisdal, L., Abramowicz, M., Abramowicz, D.

“…Summary In the 1960s, our predecessors won a historical battle against acute rejection and ensured that transplantation became a common life‐saving treatment…”
Get full text

Pulmonary artery pressure limits exercise capacity at high altitude by NAEIJE, R, HUEZ, S, LAMOTTE, M, RETAILLEAU, K, NEUPANE, S, ABRAMOWICZ, D, FAORO, V

“…Altitude exposure is associated with decreased exercise capacity and increased pulmonary vascular resistance (PVR). Echocardiographic measurements of pulmonary…”
Get full text

Old Habits Die Hard: Screening for and Treating Asymptomatic Bacteriuria After Kidney Transplantation by Coussement, J., Nagler, E. V., Abramowicz, D.

Get full text

Pharmacokinetics for Once‐ Versus Twice‐Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open‐Label Trial by Wlodarczyk, Z., Squifflet, J.‐P., Ostrowski, M., Rigotti, P., Stefoni, S., Citterio, F., Vanrenterghem, Y., Krämer, B. K., Abramowicz, D., Oppenheimer, F., Pietruck, F., Russ, G., Karpf, C., Undre, N.

“…Tacrolimus, a cornerstone immunosuppressant, is widely available as a twice‐daily formulation (Tacrolimus BID). A once‐daily prolonged‐release formulation…”
Get full text

Daclizumab Versus Rabbit Antithymocyte Globulin in High‐Risk Renal Transplants: Five‐Year Follow‐up of a Randomized Study by Hellemans, R., Hazzan, M., Durand, D., Mourad, G., Lang, P., Kessler, M., Charpentier, B., Touchard, G., Berthoux, F., Merville, P., Ouali, N., Squifflet, J.‐P., Bayle, F., Wissing, K. M., Noël, C., Abramowicz, D.

“…We previously reported a randomized controlled trial in which 227 de novo deceased‐donor kidney transplant recipients were randomized to rabbit antithymocyte…”
Get full text

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement by Covic, Adrian, Abramowicz, Daniel, Bruchfeld, Annette, Leroux-Roels, Geert, Samuel, Didier, van Biesen, Wim, Zoccali, Carmine, Zoulim, Fabien, Vanholder, Raymond

Get full text

Atypical Acute Rejection After Hand Transplantation by Schneeberger, S., Gorantla, V. S., Van Riet, R. P., Lanzetta, M., Vereecken, P., Van Holder, C., Rorive, S., Remmelink, M., Le Moine, A., Abramowicz, D., Zelger, B., Kaufman, C. L., Breidenbach, W. C., Margreiter, R., Schuind, F.

“…Skin rejection after hand transplantation is characterized by a maculopapular erythematous rash that may be diffuse, patchy or focal, and distributed over…”
Get full text

Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature by Simon, I., Wissing, K.M., Del Marmol, V., Antinori, S., Remmelink, M., Nilufer Broeders, E., Nortier, J.L., Corbellino, M., Abramowicz, D., Cascio, A.

“…I. Simon, K.M. Wissing, V. Del Marmol, S. Antinori, M. Remmelink, E. Nilufer Broeders, J.L. Nortier, M. Corbellino, D. Abramowicz, A. Cascio. Recurrent…”
Get full text

Hand Transplantation: The State-of-the-Art by SCHUIND, F., ABRAMOWICZ, D., SCHNEEBERGER, S.

“…The feasibility of hand transplantation has been demonstrated, both surgically and immunologically. Levels of immunosuppression comparable to regimens used in…”
Get full text

European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP) by Zoccali, Carmine, Abramowicz, Daniel, Cannata-Andia, Jorge B, Cochat, Pierre, Covic, Adrian, Eckardt, Kai-Uwe, Fouque, Denis, Heimburger, Olof, McLeod, Alison, Lindley, Elizabeth, Locatelli, Francesco, Spasovski, Goce, Tattersall, James, Van Biesen, Wim, Wanner, Christopher, Vanholder, Raymond

“…Although medical guidelines generally are graded according to their evidence level, low evidence 'judgement' are generally perceived as much as absolute truth…”
Get full text

Single-Center Case Series of Donor-Related Malignancies: Rare Cases With Tremendous Impact by Georgieva, L.A, Gielis, E.M, Hellemans, R, Van Craenenbroeck, A.H, Couttenye, M.M, Abramowicz, D, Van Beeumen, G, Siozopoulou, V, Van Rosmalen, M, Bracke, B, Hartman, V, De Greef, K, Roeyen, G, Chapelle, T, Ysebaert, D, Bosmans, J.L

“…Abstract Background Donor-related malignancy is a rare complication of organ transplantation. Methods In this case series, we discuss three cases of…”
Get full text

Tacrolimus Combined with Two Different Dosages of Sirolimus in Kidney Transplantation: Results of a Multicenter Study by Vitko, S., Wlodarczyk, Z., Kyllönen, L., Czajkowski, Z., Margreiter, R., Backman, L., Perner, F., Rigotti, P., Jaques, B., Abramowicz, D., Kessler, M., Sanchez‐Plumed, J., Rostaing, L., Rodger, R.S., Donati, D., Vanrenterghem, Y.

“…Tacrolimus combined with mycophenolate mofetil (MMF) is an effective regimen in kidney transplantation. This study compared the efficacy of combining…”
Get full text

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia by GERARD, C, BRUYNS, C, MARCHANT, A, ABRAMOWICZ, D, VANDENABEELE, P, DELVAUX, A, FIERS, W, GOLDMAN, M, VELU, T

“…Because of its ability to efficiently inhibit in vitro cytokine production by activated macrophages, we hypothesized that interleukin (IL) 10 might be of…”
Get full text

Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil by KUYPERS, D. R. J, VANRENTERGHEM, Y, SQUIFFLET, J. P, MOURAD, M, ABRAMOWICZ, D, OELLERICH, M, ARMSTRONG, V, SHIPKOVA, M, DAEMS, J

“…The establishment of a rationale for therapeutic drug monitoring for mycophenolic acid (MPA) and outlining a therapeutic window remains a challenging task in…”
Get full text

The Cushing Reflex: Oliguria as a Reflection of an Elevated Intracranial Pressure by Twickler, Marcel Th. B., Abramowicz, D., Menovsky, T., Mortelmans, T., Leyssens, K., Van Gaal, L.

“…Oliguria is one of the clinical hallmarks of renal failure. The broad differential diagnosis is well known, but a rare cause of oliguria is intracranial…”
Get full text

Aerobic and Anaerobic PCB Biodegradation in the Environment by Abramowicz, Daniel A.

“…Studies have identified two distinct biological processes capable of biotransforming polychlorinated biphenyls (PCBs): aerobic oxidative processes and…”
Get full text

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs by Vanherweghem, J L, Depierreux, M, Tielemans, C, Abramowicz, D, Dratwa, M, Jadoul, M, Richard, C, Vandervelde, D, Verbeelen, D, Vanhaelen-Fastre, R

“…Two similar cases of rapidly progressive fibrosing interstitial nephritis in young women who followed the same slimming regimen prompted us to conduct an…”
Get more information